Tokyo, Japan

Tatsuhisa Takahashi

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 10.9

ph-index = 4

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations of Tatsuhisa Takahashi

Introduction

Tatsuhisa Takahashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on substituted amide compounds. With a total of 6 patents to his name, Takahashi continues to push the boundaries of medical science.

Latest Patents

One of his latest patents involves a substituted amide compound that serves as an active ingredient in pharmaceutical compositions. This compound is particularly useful for treating diseases caused by lysophosphatidic acid (LPA). The chemical formula of this compound includes various components, such as an optionally substituted aryl and a 5-membered aromatic hetero ring group, among others. This innovation highlights Takahashi's commitment to developing effective treatments for complex medical conditions.

Career Highlights

Takahashi is currently associated with Astellas Pharma GmbH, where he applies his expertise in pharmaceutical research and development. His work has not only advanced the understanding of certain diseases but has also contributed to the creation of new therapeutic options for patients.

Collaborations

Throughout his career, Takahashi has collaborated with notable colleagues, including Takatoshi Kanayama and Takahiro Ishii. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new pharmaceutical solutions.

Conclusion

Tatsuhisa Takahashi's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire advancements in medical treatments, making a significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…